Work

Favorable overall survival with imetelstat in relapsed/refractory myelofibrosis patients compared with real-world data

Year: 2021

Type: article

Source: Annals of Hematology

DOI: 10.1007/s00277-021-04683-w

Authors: Andrew T. Kuykendall, Libo Sun, John Mascarenhas, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Julia Wang, Qi Xia, Eugene Zhu, Faye Feller, Aleksandra Rizo, Jacqueline Bussolari, Ying Wan, Rami Komrokji

Institutions: Moffitt Cancer Center, Geron (United States), Icahn School of Medicine at Mount Sinai, Hôpital Saint-Louis, University of Florence, Janssen Research & Development (United States)

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3202626951

FWCI: 2.807

Cites: 23

Cited by: 26

Related to: 10